Vitamin D and prebiotics for intestinal health in cystic fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 x 2 trial of administration of prebiotics and cholecalciferol (vitamin D3) (Pre-D trial) in adults with cystic fibrosis.
Saved in:
| Title: | Vitamin D and prebiotics for intestinal health in cystic fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 x 2 trial of administration of prebiotics and cholecalciferol (vitamin D |
|---|---|
| Authors: | Sivapiromrat AK; Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.; Emory College, Emory University, Atlanta, GA, USA., Suppakitjanusant P; Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.; Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand., Wang Y; Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA., Hu C; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA., Binongo J; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA., Hunt WR; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA., Weinstein S; Emory College, Emory University, Atlanta, GA, USA., Jathal I; Emory College, Emory University, Atlanta, GA, USA., Alvarez JA; Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA., Chassaing B; INSERM U1016, Team 'Mucosal Microbiota in Chronic Inflammatory Diseases', CNRS, UMR, 8104, Université Paris Cité, Paris, France., Ziegler TR; Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.; Atlanta VA Medical Center, Decatur, GA, USA., Gewirtz AT; Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA., Tangpricha V; Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.; Atlanta VA Medical Center, Decatur, GA, USA. |
| Source: | Contemporary clinical trials communications [Contemp Clin Trials Commun] 2024 Feb 18; Vol. 38, pp. 101278. Date of Electronic Publication: 2024 Feb 18 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101671157 Publication Model: eCollection Cited Medium: Internet ISSN: 2451-8654 (Electronic) Linking ISSN: 24518654 NLM ISO Abbreviation: Contemp Clin Trials Commun Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38435430 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Vitamin D and prebiotics for intestinal health in cystic fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 x 2 trial of administration of prebiotics and cholecalciferol (vitamin D<subscript>3</subscript>) (Pre-D trial) in adults with cystic fibrosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sivapiromrat+AK%22">Sivapiromrat AK</searchLink>; Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.; Emory College, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Suppakitjanusant+P%22">Suppakitjanusant P</searchLink>; Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.; Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Hu+C%22">Hu C</searchLink>; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Binongo+J%22">Binongo J</searchLink>; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Hunt+WR%22">Hunt WR</searchLink>; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Weinstein+S%22">Weinstein S</searchLink>; Emory College, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Jathal+I%22">Jathal I</searchLink>; Emory College, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Alvarez+JA%22">Alvarez JA</searchLink>; Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Chassaing+B%22">Chassaing B</searchLink>; INSERM U1016, Team 'Mucosal Microbiota in Chronic Inflammatory Diseases', CNRS, UMR, 8104, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Ziegler+TR%22">Ziegler TR</searchLink>; Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.; Atlanta VA Medical Center, Decatur, GA, USA.<br /><searchLink fieldCode="AU" term="%22Gewirtz+AT%22">Gewirtz AT</searchLink>; Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Tangpricha+V%22">Tangpricha V</searchLink>; Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.; Atlanta VA Medical Center, Decatur, GA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101671157%22">Contemporary clinical trials communications</searchLink> [Contemp Clin Trials Commun] 2024 Feb 18; Vol. 38, pp. 101278. <i>Date of Electronic Publication: </i>2024 Feb 18 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101671157 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2451-8654 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224518654%22">24518654 </searchLink><i>NLM ISO Abbreviation: </i>Contemp Clin Trials Commun <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38435430 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.conctc.2024.101278 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 101278 Titles: – TitleFull: Vitamin D and prebiotics for intestinal health in cystic fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 x 2 trial of administration of prebiotics and cholecalciferol (vitamin D3) (Pre-D trial) in adults with cystic fibrosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sivapiromrat AK – PersonEntity: Name: NameFull: Suppakitjanusant P – PersonEntity: Name: NameFull: Wang Y – PersonEntity: Name: NameFull: Hu C – PersonEntity: Name: NameFull: Binongo J – PersonEntity: Name: NameFull: Hunt WR – PersonEntity: Name: NameFull: Weinstein S – PersonEntity: Name: NameFull: Jathal I – PersonEntity: Name: NameFull: Alvarez JA – PersonEntity: Name: NameFull: Chassaing B – PersonEntity: Name: NameFull: Ziegler TR – PersonEntity: Name: NameFull: Gewirtz AT – PersonEntity: Name: NameFull: Tangpricha V IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 02 Text: 2024 Feb 18 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2451-8654 Numbering: – Type: volume Value: 38 Titles: – TitleFull: Contemporary clinical trials communications Type: main |
| ResultId | 1 |
